Koyfin Home > Directory > Health Care > Adamas Pharma > Net Income Margin

Adamas Pharma Net Income Margin Chart (ADMS)

Adamas Pharma annual/quarterly Net Income Margin from 2012 to 2020. Net profit margin, or net margin, is equal to net income or profits divided by total revenue and represents how much profit each dollar of sales generates. Net profit margin is the ratio of net profits or net income to revenues for a company.
  • Adamas Pharma Net Income Margin for the quarter ending June 06, 2020 was $-56m a -252.12% increase of 142m year over year
  • Adamas Pharma Net Income Margin for the last 12 months ending June 06, 2020 was $-123m a -75.55% increase of 93m year over year
  • Adamas Pharma Annual Net Income Margin for 2019 was $-193m a -99.86% increase of 192m from 2018
  • Adamas Pharma Annual Net Income Margin for 2018 was $-385m a -3,973.21% increase of 15,288m from 2017
  • Adamas Pharma Annual Net Income Margin for 2017 was $-15,673m a 33.01% decrease of -5,173m from 2016
Other Margins & Efficiency Metrics:
  • Adamas Pharma EBITDA Margin for the quarter ending December 12, 2018 was $-187m a 135.57% decrease of -254m year over year
  • Adamas Pharma Return on Capital % for the quarter ending September 09, 2018 was -29.66 a -68.05% increase of 20.18 year over year
  • Adamas Pharma Return on Equity % for the quarter ending September 09, 2018 was -103.21 a -49.69% increase of 51.29 year over year
View Chart On Koyfin

Quarterly ADMS Net Income Margin Data

06/2020$-56m
03/2020$-115m
12/2019$-141m
09/2019$-198m
06/2019$-196m
03/2019$-254m
12/2018$-217m
09/2018$-312m
06/2018$-449m
03/2018$-1,370m

Annual ADMS Net Income Margin Data

2019$-193m
2018$-385m
2017$-15,673m
2016$-10,500m
2015$-2,704m
2014$18m
2013$72m
2012$47m
2011$-416m